We show here that inhibition of XPO1-mediated nucleocytoplasmic transport blocked growth in vitro, induced tumor regression in vivo in a transgenic mouse, and inhibited human HCC PDX, more effectively in MYChigh cancers. Here, XPO1 is linked to cancer.